Agenus jumps on cancer drug partnership with India's Zydus

Agenus

03/06/2025 12:49

** Shares of cancer therapy developer Agenus AGEN.O rise 33.4% to $5.51 premarket

** AGEN and India-based Zydus Lifesciences ZYDU.NS have entered a $141 mln partnership to advance cancer immunotherapy drugs

** Agenus will receive $75 mln upfront and potentially $50 mln more from Zydus for transferring its biologics manufacturing facilities, the cos say

** Zydus is making a $16 mln equity investment in Agenus by purchasing shares at $7.50 each

** As of last close, AGEN up 50.7% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))